Health ❯ Healthcare ❯ Clinical Trials ❯ Patient Outcomes

Survival Rates

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

NHS England has struck a deal with MSD to fund immediate access through the Cancer Drugs Fund and expects about 550 patients to be eligible over two years.

7 ARTICLES

3w ago

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

35 ARTICLES

4w ago

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

6 ARTICLES

last mo.

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

3 ARTICLES

2mo ago

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

3 ARTICLES

5mo ago

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

6 ARTICLES

6mo ago

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

4 ARTICLES

8mo ago

Spanish Dual-Target CAR-T With Low-Intensity Transplant Shows Promising Pediatric Survival

29 ARTICLES

8mo ago

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

3 ARTICLES

10mo ago

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

9 ARTICLES

last yr.

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

33 ARTICLES

last yr.

Structured exercise rivals drug efficacy in slashing colon cancer recurrence and mortality

7 ARTICLES

last yr.

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

6 ARTICLES

last yr.

Statins Linked to 61% Reduced Cancer Mortality in CLL and SLL Patients

4 ARTICLES

last yr.

New Three-Drug Therapy Doubles Survival Time for Advanced Breast Cancer Patients

Survival Rates

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Spanish Dual-Target CAR-T With Low-Intensity Transplant Shows Promising Pediatric Survival

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

Statins Linked to 39% Drop in 28-Day Mortality for Sepsis Patients

Structured exercise rivals drug efficacy in slashing colon cancer recurrence and mortality

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

Statins Linked to 61% Reduced Cancer Mortality in CLL and SLL Patients

New Three-Drug Therapy Doubles Survival Time for Advanced Breast Cancer Patients

Never miss stories about

Survival Rates